Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Miconazole nitrate
Janssen-Cilag Ltd
G01AF04
Miconazole nitrate
20 milligram(s)/gram
Vaginal cream
Product subject to prescription which may be renewed (B)
miconazole
Marketed
1987-11-06
PACKAGE LEAFLET: INFORMATION FOR THE USER GYNO-DAKTARIN ® 20 MG/G VAGINAL CREAM Miconazole nitrate Gyno-Daktarin is a registered trademark READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1 What Gyno-Daktarin cream is and what it is used for 2 What you need to know before you use Gyno-Daktarin cream 3 How to use Gyno-Daktarin cream 4 Possible side effects 5 How to store Gyno-Daktarin cream 6 Contents of the pack and other information 1 WHAT GYNO-DAKTARIN CREAM IS AND WHAT IT IS USED FOR The name of your medicine is Gyno-Daktarin 20 mg/g vaginal cream. In this leaflet it is called Gyno-Daktarin cream. Gyno-Daktarin cream is for use in adults. Gyno-Daktarin cream contains a medicine called miconazole nitrate. This belongs to a group of medicines called ‘antifungals’. Gyno-Daktarin cream is used for infections of the vagina and the skin around the vagina. Signs of these infections include itching, redness and white discharge. The infections, such as thrush (_Candida_), are caused by fungi and yeasts. Gyno-Daktarin cream works by destroying the fungus that causes the infection and some of the bacteria which may also be present. Your sexual partner may also need to be treated. Ask your doctor for advice. ABOUT VAGINAL THRUSH Vaginal thrush is a very common problem affecting women of all ages. It has nothing to do with poor hygiene. It is often caused by a fungus (_Candida _ _albicans_) that is present in everybody. The fungus is normally kept in check by the body’s defences. Sometimes the fungus ca Read the complete document
Health Products Regulatory Authority 19 November 2018 CRN008LPD Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gyno-Daktarin 20mg/gvaginal cream. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Miconazole nitrate 2% w/w Each gram of cream contains 20 mg miconazole nitrate. Excipients: Each gram of cream contains 2mg benzoic acid and 5 micrograms of butylated hydroxyanisole. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Vaginal cream. The cream is white and homogeneous. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Gyno-Daktarin is for the local treatment of vulvo-vaginal candidosis and superinfection due to susceptible Gram-positive bacteria. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Gyno-Daktarin cream is for vaginal administration. Adults (aged 18 years and older): The contents of two applicators (10 g of cream) inserted high into the vagina at night for 7 days. Alternatively, the contents of one applicator inserted high into the vagina at night for 14 days. Continue the full 7 or 14 day course of treatment even after pruritus and leukorrhoea have disappeared or menstruation begins. Paediatrics (aged under 18 years) The safety and efficacy of Gyno-Daktarin cream in children and adolescents has not been studied. Health Products Regulatory Authority 19 November 2018 CRN008LPD Page 2 of 8 4.3 CONTRAINDICATIONS Gyno-Daktarin cream is contraindicated in individuals with a known hypersensitivity to miconazole/miconazole nitrate, other imidazole derivatives or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported during treatment with Gyno-Daktarin cream and with other miconazole formulations (see section 4.8). If a reaction suggesting hypersensitivity or irritation should occur, the treatment should be discontinued. Absorption of the antifungal may occur through denuded mucosa. To date there have been no reports of systematic adverse e Read the complete document